Invesaro

Stocks ATRA Earnings

Earnings

Atara Biotherapeutics, Inc. (ATRA) earnings

Quarterly results of Atara Biotherapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when ATRA files with the SEC.

Next earnings date

Atara Biotherapeutics, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Atara Biotherapeutics, Inc. reported revenue of $630K (-96.4% on the same quarter a year earlier) and a net loss of $4.8M.

Diluted earnings per share were -$0.32.

Filed with the SEC on August 12, 2026.

Revenue by quarter
Q3 24: $40.2M $40.2M Q3 24Q4 24: $32.8M $32.8M Q4 24Q1 25: $98.1M $98.1M Q1 25Q2 25: $17.6M $17.6M Q2 25Q3 25: $3.5M $3.5M Q3 25Q4 25: $1.6M $1.6M Q4 25Q1 26: $516K $516K Q1 26Q2 26: $630K $630K Q2 26
Net income by quarter
Q3 24: -$21.9M -$21.9M Q3 24Q4 24: -$12.7M -$12.7M Q4 24Q1 25: $38M $38M Q1 25Q2 25: $2.4M $2.4M Q2 25Q3 25: -$4.3M -$4.3M Q3 25Q4 25: -$3.4M -$3.4M Q4 25Q1 26: -$4.1M -$4.1M Q1 26Q2 26: -$4.8M -$4.8M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$630K-96.4%-$4.8M-$0.32
Q1 FY2026March 31, 2026$516K-99.5%-$4.1M-$0.29
Q4 FY2025December 31, 2025$1.6M-95.1%-$3.4M-
Q3 FY2025September 30, 2025$3.5M-91.4%-$4.3M-$0.32
Q2 FY2025June 30, 2025$17.6M-$2.4M$0.19
Q1 FY2025March 31, 2025$98.1M-$38M$3.50
Q4 FY2024December 31, 2024$32.8M--$12.7M-
Q3 FY2024September 30, 2024$40.2M--$21.9M-$2.93

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Atara Biotherapeutics, Inc.'s next earnings date?

Atara Biotherapeutics, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Atara Biotherapeutics, Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, Atara Biotherapeutics, Inc. reported revenue of $630K and a net loss of $4.8M. The figures come from its filing with the SEC.

Is Atara Biotherapeutics, Inc.'s revenue growing?

Revenue in Q2 FY2026 was $630K, down 96.4% from $17.6M in the same quarter a year earlier.

Get an email when ATRA reports

Follow ATRA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when ATRA files with the SEC.

Source: quarterly figures Atara Biotherapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Atara Biotherapeutics, Inc.